or
Remember me
Back
Recommend this post on Thiogenesis Therapeutics Corp. (TTI.v TTIPF) and the development of the drug TTI-0102 which is designed to treat pediatric NASH by releasing cysteamine, a potent antioxidant that can reduce oxidative stress and inflammation.
Full post here: https://www.reddit.com/r/Penny_Stocks_Canada/comments/1hwu7ud/thiogenesis_therapeutics_corp_ttiv_ttipf/
*Posted on behalf of Thiogenesis Therapeutics Corp.
Receive investor kits and email updates from Stockhouse and directly from these companies.